Erratum to “Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19”

Erratum to “Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19”

Saved in:

Bibliographic Details
Main Authors:	Aliede E. in ‘t Veld, Manon A. A. Jansen, Luuk C. A. Ciere, Matthijs Moerland
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2021/9789246
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Elhwuegi
Published: (2020-01-01)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
by: Xiaoxuan Sun, et al.
Published: (2020-01-01)

Reply to: On meta-analytic models and the effect of hydroxychloroquine use in COVID-19
by: Andreas M. Schmitt, et al.
Published: (2025-07-01)

The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19
by: Yu. N. Belenkov, et al.
Published: (2020-12-01)

Utility of hydroxychloroquine for COVID-19: Are we hoping against hope?
by: K C Manish, et al.
Published: (2021-01-01)

On meta-analytic models and the effect of hydroxychloroquine use in COVID-19
by: Diego Pasquier
Published: (2025-07-01)

CHLOROQUINE AND HYDROXYCHLOROQUINE ARE AVAILABLE TREATMENT OPTIONS TO FIGHT WITH COVID-19
by: Shadia S. Alhamd, et al.
Published: (2020-11-01)

Hydroxychloroquine in COVID-19 widespread use despite unproven benefit
by: Pranav Ish
Published: (2022-01-01)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
by: Mondher Toumi, et al.
Published: (2020-01-01)

Long-term application of hydroxychloroquine could not prevent the infection of COVID-19
by: Yin Zhu, et al.
Published: (2020-12-01)

Usefulness of hydroxychloroquine for COVID-19: Does answer lie in timing to start?
by: Mohan Gurjar, et al.
Published: (2020-01-01)

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine
by: Latarissa IR, et al.
Published: (2025-01-01)

DAMPening Inflammation by Modulating TLR Signalling
by: A. M. Piccinini, et al.
Published: (2010-01-01)

The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis
by: Teshale Ayele Mega, et al.
Published: (2020-01-01)

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety
by: Alain Cornet, et al.
Published: (2021-04-01)

Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
by: Adam Jan Ząbek, et al.
Published: (2025-04-01)

Prognostic significance of <I>TLR3</I> and <I>TLR9</I> gene polymorphism in assessing the severity of COVID-19
by: L. A. Ashchina, et al.
Published: (2024-04-01)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
by: Juan Macías, et al.
Published: (2021-01-01)

Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
by: Anis Saib, et al.
Published: (2021-01-01)

Rheumatologists’ perspective on hydroxychloroquine guidelines
by: Anca D Askanase, et al.
Published: (2020-10-01)

Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
by: Cathrine Axfors, et al.
Published: (2021-04-01)

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
by: Mark Stewart, et al.
Published: (2021-01-01)

Erratum to “Increased Expression of TLR10 in B Cell Subsets Correlates with Disease Activity in Rheumatoid Arthritis”
by: Ying Zhang, et al.
Published: (2019-01-01)

Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone
by: Satriyo Dwi Suryantoro, et al.
Published: (2021-09-01)

Exploring the Role of News Outlets in the Rise of a Conspiracy Theory: Hydroxychloroquine in the Early Days of COVID-19
by: Robert Dickinson, et al.
Published: (2024-11-01)

Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients
by: Ahmet Omma, et al.
Published: (2022-01-01)

Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01)

Hydroxychloroquine in rheumatic autoimmune disorders and beyond
by: Eliise Laura Nirk, et al.
Published: (2020-07-01)

Physical activity levels, gut permeability, circulating inflammatory cytokines and TLR4 signalling in PBMCs of COVID-19 patients
by: Hermann Zbinden-Foncea, et al.
Published: (2024-03-01)

“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency.
by: NICOLA SGHERZA, et al.
Published: (2020-10-01)

Insights on the role of TLR-4 in neuroinflammation: a hint on COVID-19 relationship
by: Salma A. Elshafey, et al.
Published: (2023-12-01)

Combined disease modifying treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine
by: N A Sergiets, et al.
Published: (2009-02-01)

Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
by: Long Ge, et al.
Published: (2022-03-01)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
by: Shalini Bhaskar, et al.
Published: (2022-01-01)

Mechanisms and roles of hydroxychloroquine in pregnancy in rheumatic diseases
by: Lingjun Kong, et al.
Published: (2025-02-01)

Hydroxychloroquine Induced Retinopathy: A Case Series
by: Maryam Mobini, et al.
Published: (2016-10-01)

Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study
by: Saja H. Almazrou, et al.
Published: (2020-12-01)

Raddeanin A promotes the apoptosis of gastric cancer in conjunction with autophagy inhibitor Hydroxychloroquine via MAPK signaling pathway
by: Yuhao Teng, et al.
Published: (2025-03-01)

TLR2 and TLR4 in Ischemia Reperfusion Injury
by: F. Arslan, et al.
Published: (2010-01-01)